nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethopropazine—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.0417	0.152	CbGeAlD
Ethopropazine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0295	0.0462	CbGpPWpGaD
Ethopropazine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0251	0.0393	CbGpPWpGaD
Ethopropazine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0249	0.039	CbGpPWpGaD
Ethopropazine—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.0227	0.0827	CbGeAlD
Ethopropazine—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.0218	0.0796	CbGeAlD
Ethopropazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0183	0.0666	CbGeAlD
Ethopropazine—GRIN3A—brain—attention deficit hyperactivity disorder	0.0173	0.0632	CbGeAlD
Ethopropazine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.0166	0.0606	CbGeAlD
Ethopropazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.0154	0.0563	CbGeAlD
Ethopropazine—CHRM1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0149	0.0233	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0147	0.023	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0146	0.0228	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0144	0.0225	CbGpPWpGaD
Ethopropazine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.014	0.0513	CbGeAlD
Ethopropazine—CHRM1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0125	0.0196	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0124	0.0193	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0123	0.0192	CbGpPWpGaD
Ethopropazine—BCHE—forebrain—attention deficit hyperactivity disorder	0.0121	0.0443	CbGeAlD
Ethopropazine—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0121	0.019	CbGpPWpGaD
Ethopropazine—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.0103	0.0374	CbGeAlD
Ethopropazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00991	0.0362	CbGeAlD
Ethopropazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00954	0.0348	CbGeAlD
Ethopropazine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00902	0.0329	CbGeAlD
Ethopropazine—CHRM1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00883	0.0138	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00872	0.0137	CbGpPWpGaD
Ethopropazine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00868	0.0317	CbGeAlD
Ethopropazine—CHRM1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0085	0.0133	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00839	0.0131	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00821	0.0129	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00811	0.0127	CbGpPWpGaD
Ethopropazine—BCHE—midbrain—attention deficit hyperactivity disorder	0.00801	0.0292	CbGeAlD
Ethopropazine—CHRM1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00795	0.0125	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00785	0.0123	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00782	0.0122	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00772	0.0121	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00772	0.0121	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00762	0.0119	CbGpPWpGaD
Ethopropazine—CHRM2—brain—attention deficit hyperactivity disorder	0.00757	0.0276	CbGeAlD
Ethopropazine—CHRM1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00743	0.0116	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00733	0.0115	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00719	0.0113	CbGpPWpGaD
Ethopropazine—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0071	0.0111	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0069	0.0108	CbGpPWpGaD
Ethopropazine—CHRM1—brain—attention deficit hyperactivity disorder	0.00689	0.0252	CbGeAlD
Ethopropazine—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00682	0.0107	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00669	0.0105	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0066	0.0103	CbGpPWpGaD
Ethopropazine—BCHE—nervous system—attention deficit hyperactivity disorder	0.00659	0.024	CbGeAlD
Ethopropazine—CHRM1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00657	0.0103	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00649	0.0102	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00649	0.0102	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00641	0.01	CbGpPWpGaD
Ethopropazine—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00634	0.0231	CbGeAlD
Ethopropazine—BCHE—cerebellum—attention deficit hyperactivity disorder	0.0062	0.0226	CbGeAlD
Ethopropazine—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00616	0.00964	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00605	0.00947	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00597	0.00935	CbGpPWpGaD
Ethopropazine—CHRM1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00504	0.00789	CbGpPWpGaD
Ethopropazine—BCHE—brain—attention deficit hyperactivity disorder	0.00504	0.0184	CbGeAlD
Ethopropazine—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00497	0.00779	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00472	0.00739	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00456	0.00714	CbGpPWpGaD
Ethopropazine—CHRM1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00424	0.00663	CbGpPWpGaD
Ethopropazine—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00418	0.00655	CbGpPWpGaD
Ethopropazine—Diethylpropion—SLC6A3—attention deficit hyperactivity disorder	0.00395	0.0451	CrCbGaD
Ethopropazine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00349	0.00546	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00339	0.0053	CbGpPWpGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00315	0.00494	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00306	0.00479	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00293	0.00458	CbGpPWpGaD
Ethopropazine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00291	0.0332	CrCbGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00287	0.0045	CbGpPWpGaD
Ethopropazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.00287	0.0328	CrCbGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00284	0.00444	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00281	0.00441	CbGpPWpGaD
Ethopropazine—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00281	0.00441	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00279	0.00438	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00278	0.00435	CbGpPWpGaD
Ethopropazine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00278	0.00435	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00276	0.00432	CbGpPWpGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00271	0.00424	CbGpPWpGaD
Ethopropazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.00257	0.0294	CrCbGaD
Ethopropazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.00253	0.029	CrCbGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00252	0.00395	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00252	0.00394	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00246	0.00385	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00243	0.00381	CbGpPWpGaD
Ethopropazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.00242	0.0277	CrCbGaD
Ethopropazine—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00242	0.00379	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00241	0.00378	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00241	0.00378	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00238	0.00373	CbGpPWpGaD
Ethopropazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.00236	0.0269	CrCbGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00234	0.00367	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00234	0.00367	CbGpPWpGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00225	0.00352	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00221	0.00346	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00208	0.00325	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00207	0.00325	CbGpPWpGaD
Ethopropazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.00202	0.0231	CrCbGaD
Ethopropazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00196	0.0224	CrCbGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00195	0.00306	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00194	0.00303	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00194	0.00303	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00193	0.00302	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00193	0.00302	CbGpPWpGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00191	0.00299	CbGpPWpGaD
Ethopropazine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0019	0.00297	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00187	0.00294	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00187	0.00294	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00185	0.0029	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00184	0.00288	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00182	0.00285	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00181	0.00284	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00181	0.00284	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00176	0.00276	CbGpPWpGaD
Ethopropazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.00176	0.0201	CrCbGaD
Ethopropazine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00172	0.00269	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00267	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.0017	0.00266	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.0017	0.00266	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00168	0.00264	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00167	0.00262	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00165	0.00258	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00163	0.00256	CbGpPWpGaD
Ethopropazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.00163	0.0186	CrCbGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00161	0.00251	CbGpPWpGaD
Ethopropazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.00159	0.0182	CrCbGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00159	0.00248	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00159	0.00248	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00158	0.00247	CbGpPWpGaD
Ethopropazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.00157	0.018	CrCbGaD
Ethopropazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.00157	0.0179	CrCbGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00156	0.00245	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00156	0.00244	CbGpPWpGaD
Ethopropazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.00154	0.0176	CrCbGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00154	0.0024	CbGpPWpGaD
Ethopropazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00152	0.0174	CrCbGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00152	0.00237	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00151	0.00236	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00149	0.00233	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00149	0.00233	CbGpPWpGaD
Ethopropazine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00148	0.00231	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00147	0.0023	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00146	0.00229	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00229	CbGpPWpGaD
Ethopropazine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00145	0.00227	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00144	0.00226	CbGpPWpGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00144	0.00225	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00143	0.00225	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00142	0.00222	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00139	0.00217	CbGpPWpGaD
Ethopropazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.00138	0.0158	CrCbGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00137	0.00215	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00136	0.00213	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00134	0.0021	CbGpPWpGaD
Ethopropazine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00132	0.0151	CrCbGaD
Ethopropazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.00132	0.015	CrCbGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00132	0.00206	CbGpPWpGaD
Ethopropazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.0013	0.0149	CrCbGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0013	0.00203	CbGpPWpGaD
Ethopropazine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.0148	CrCbGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00129	0.00202	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00128	0.002	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.002	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00127	0.00199	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00126	0.00197	CbGpPWpGaD
Ethopropazine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00126	0.00197	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00126	0.00197	CbGpPWpGaD
Ethopropazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.00124	0.0142	CrCbGaD
Ethopropazine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.0142	CrCbGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00119	0.00186	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00117	0.00184	CbGpPWpGaD
Ethopropazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.00117	0.0133	CrCbGaD
Ethopropazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.00115	0.0131	CrCbGaD
Ethopropazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00114	0.013	CrCbGaD
Ethopropazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.00113	0.013	CrCbGaD
Ethopropazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00113	0.00176	CbGpPWpGaD
Ethopropazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.00112	0.0128	CrCbGaD
Ethopropazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.00111	0.0127	CrCbGaD
Ethopropazine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00174	CbGpPWpGaD
Ethopropazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.0011	0.0126	CrCbGaD
Ethopropazine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00172	CbGpPWpGaD
Ethopropazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.00109	0.0125	CrCbGaD
Ethopropazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.0124	CrCbGaD
Ethopropazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00108	0.0123	CrCbGaD
Ethopropazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.00107	0.0122	CrCbGaD
Ethopropazine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.00166	CbGpPWpGaD
Ethopropazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.00106	0.0121	CrCbGaD
Ethopropazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00106	0.0121	CrCbGaD
Ethopropazine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00164	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00104	0.00163	CbGpPWpGaD
Ethopropazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.0118	CrCbGaD
Ethopropazine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00103	0.00162	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00102	0.0016	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00102	0.0016	CbGpPWpGaD
Ethopropazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.001	0.0115	CrCbGaD
Ethopropazine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.001	0.00157	CbGpPWpGaD
Ethopropazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000994	0.0114	CrCbGaD
Ethopropazine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000989	0.00155	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000984	0.00154	CbGpPWpGaD
Ethopropazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000972	0.00152	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000972	0.00152	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000972	0.00152	CbGpPWpGaD
Ethopropazine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000965	0.011	CrCbGaD
Ethopropazine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000962	0.00151	CbGpPWpGaD
Ethopropazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00096	0.0015	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00096	0.0015	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000949	0.00149	CbGpPWpGaD
Ethopropazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.000944	0.0108	CrCbGaD
Ethopropazine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000942	0.00148	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00093	0.00146	CbGpPWpGaD
Ethopropazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	0.000918	0.0105	CrCbGaD
Ethopropazine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000906	0.00142	CbGpPWpGaD
Ethopropazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000897	0.0102	CrCbGaD
Ethopropazine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000894	0.0014	CbGpPWpGaD
Ethopropazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.000887	0.0101	CrCbGaD
Ethopropazine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000881	0.00138	CbGpPWpGaD
Ethopropazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	0.000867	0.00991	CrCbGaD
Ethopropazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.000865	0.00989	CrCbGaD
Ethopropazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	0.000853	0.00975	CrCbGaD
Ethopropazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.000849	0.00971	CrCbGaD
Ethopropazine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000847	0.00133	CbGpPWpGaD
Ethopropazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.000842	0.00963	CrCbGaD
Ethopropazine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000836	0.00131	CbGpPWpGaD
Ethopropazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000833	0.0013	CbGpPWpGaD
Ethopropazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000822	0.00129	CbGpPWpGaD
Ethopropazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.000822	0.0094	CrCbGaD
Ethopropazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.000807	0.00923	CrCbGaD
Ethopropazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.000803	0.00918	CrCbGaD
Ethopropazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.000801	0.00915	CrCbGaD
Ethopropazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.000789	0.00902	CrCbGaD
Ethopropazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	0.000785	0.00897	CrCbGaD
Ethopropazine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.000773	0.00884	CrCbGaD
Ethopropazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	0.000763	0.00872	CrCbGaD
Ethopropazine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00076	0.00119	CbGpPWpGaD
Ethopropazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.000755	0.00863	CrCbGaD
Ethopropazine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000719	0.00113	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00071	0.00111	CbGpPWpGaD
Ethopropazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	0.000709	0.00811	CrCbGaD
Ethopropazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	0.000706	0.00807	CrCbGaD
Ethopropazine—Desipramine—DRD2—attention deficit hyperactivity disorder	0.000702	0.00803	CrCbGaD
Ethopropazine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00068	0.00778	CrCbGaD
Ethopropazine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000661	0.00104	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000653	0.00102	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000653	0.00102	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000645	0.00101	CbGpPWpGaD
Ethopropazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.000635	0.00726	CrCbGaD
Ethopropazine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000634	0.000994	CbGpPWpGaD
Ethopropazine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000629	0.000985	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000629	0.000985	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000626	0.000981	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000621	0.000972	CbGpPWpGaD
Ethopropazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.00062	0.00709	CrCbGaD
Ethopropazine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000608	0.000952	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000608	0.000952	CbGpPWpGaD
Ethopropazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	0.000606	0.00693	CrCbGaD
Ethopropazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.000599	0.00685	CrCbGaD
Ethopropazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	0.000599	0.00684	CrCbGaD
Ethopropazine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000598	0.000937	CbGpPWpGaD
Ethopropazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.000597	0.00683	CrCbGaD
Ethopropazine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.000596	0.00681	CrCbGaD
Ethopropazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	0.000589	0.00674	CrCbGaD
Ethopropazine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000584	0.000915	CbGpPWpGaD
Ethopropazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.000583	0.00667	CrCbGaD
Ethopropazine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000577	0.000904	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000571	0.000894	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000568	0.00089	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000566	0.000886	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000564	0.000883	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000561	0.000878	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000559	0.000875	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000557	0.000872	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000556	0.000871	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000556	0.000871	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000549	0.000861	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000549	0.000861	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000549	0.00086	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000546	0.000855	CbGpPWpGaD
Ethopropazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	0.000543	0.0062	CrCbGaD
Ethopropazine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000542	0.00085	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000539	0.000844	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000531	0.000831	CbGpPWpGaD
Ethopropazine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000526	0.00601	CrCbGaD
Ethopropazine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000524	0.000821	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000514	0.000805	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000512	0.000802	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000507	0.000795	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000505	0.000791	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000505	0.000791	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000499	0.000782	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000499	0.000781	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000493	0.000771	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000486	0.000761	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000465	0.000728	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000463	0.000725	CbGpPWpGaD
Ethopropazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	0.000463	0.00529	CrCbGaD
Ethopropazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.00046	0.00526	CrCbGaD
Ethopropazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000459	0.000719	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000386	0.000604	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000381	0.000597	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000368	0.000577	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000366	0.000573	CbGpPWpGaD
Ethopropazine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000358	0.000562	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000355	0.000556	CbGpPWpGaD
Ethopropazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000354	0.000554	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000337	0.000528	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000333	0.000521	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000326	0.00051	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000321	0.000503	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000313	0.000491	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000309	0.000485	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000304	0.000476	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0003	0.000469	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000298	0.000467	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000295	0.000462	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000295	0.000461	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000291	0.000456	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000275	0.00043	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000271	0.000425	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000192	0.000301	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00019	0.000297	CbGpPWpGaD
Ethopropazine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000158	0.000247	CbGpPWpGaD
Ethopropazine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000102	0.00016	CbGpPWpGaD
Ethopropazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000101	0.000158	CbGpPWpGaD
